Top FDA official cancels staff to approve failed gene therapy trial

Larger / Dr. Peter Marks, Director of the Center for Biological Evaluation and Research within the Food and Drug Administration on March 18, 2021 in Washington, DC. The Food and Drug Administration (FDA) on Thursday announced expanded approval for a gene therapy to treat Duchenne muscular dystrophy (DMD) — despite the fact that it failed … Read more

Nvidia and Palantir: Argus’ top analysts pick the best AI stocks to buy

AI has generated headlines as well as improved computing capabilities in recent months. Since the arrival of generative artificial intelligence with the launch of ChatGPT in 2022, the new technology has taken the tech world and the wider economy by storm. The impact of AI has been felt in everything from supercomputers and semiconductor chip … Read more